 LEWISVILLE, Texas--BUSINESS WIRE--Orthofix Medical Inc. NASDAQ:OFIX today reported its financial results for the quarter ended June 30, 2021. Net sales were 121 million, earnings per share EPS was 0.12, and adjusted EPS was 0.32. We are proud of our second quarter performance, in which we delivered accelerated topline growth sequentially and over pre-COVID levels, said Orthofix President and Chief Executive Officer Jon Serbousek. We continue to see the positive impacts of our stra 